NASDAQ:PLSE Pulse Biosciences (PLSE) Stock Price, News & Analysis $14.56 -2.87 (-16.47%) (As of 11/1/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Pulse Biosciences Stock (NASDAQ:PLSE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Pulse Biosciences alerts:Sign Up Key Stats Today's Range$14.06▼$17.4950-Day Range$15.60▼$21.4852-Week Range$4.35▼$22.69Volume402,389 shsAverage Volume201,590 shsMarket Capitalization$892.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.Read More… Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Pulse Biosciences Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks28th Percentile Overall ScorePLSE MarketRank™: Pulse Biosciences scored higher than 28% of companies evaluated by MarketBeat, and ranked 845th out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Pulse Biosciences.Read more about Pulse Biosciences' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioPulse Biosciences has a P/B Ratio of 17.98. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Pulse Biosciences' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.15% of the float of Pulse Biosciences has been sold short.Short Interest Ratio / Days to CoverPulse Biosciences has a short interest ratio ("days to cover") of 17.2, which indicates bearish sentiment.Change versus previous monthShort interest in Pulse Biosciences has recently decreased by 0.72%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPulse Biosciences does not currently pay a dividend.Dividend GrowthPulse Biosciences does not have a long track record of dividend growth. Sustainability and ESG4.2 / 5Environmental Score-0.60 Percentage of Shares Shorted16.15% of the float of Pulse Biosciences has been sold short.Short Interest Ratio / Days to CoverPulse Biosciences has a short interest ratio ("days to cover") of 17.2, which indicates bearish sentiment.Change versus previous monthShort interest in Pulse Biosciences has recently decreased by 0.72%, indicating that investor sentiment is improving. News and Social Media2.5 / 5News Sentiment0.48 News SentimentPulse Biosciences has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Pulse Biosciences this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for PLSE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Pulse Biosciences insiders have not sold or bought any company stock.Percentage Held by Insiders71.50% of the stock of Pulse Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions76.95% of the stock of Pulse Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Pulse Biosciences' insider trading history. Receive PLSE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address PLSE Stock News HeadlinesPulse Biosciences (NASDAQ:PLSE) Stock Quotes, Forecast and News SummaryNovember 1 at 8:03 PM | benzinga.comPulse Biosciences Reports Q3 2024 Financials and DevelopmentsNovember 1 at 4:59 AM | markets.businessinsider.comThis is treasonIf you missed it, my emergency election broadcast is now available - but will be removed soonNovember 2, 2024 | Porter & Company (Ad)Pulse Biosciences Inc (6L8.MU)October 31 at 6:56 PM | ca.finance.yahoo.comPulse Biosciences Reports Positive Data From Benign Thyroid StudyOctober 31 at 6:56 PM | marketwatch.comPulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid AssociationOctober 31 at 2:25 PM | businesswire.comPulse Biosciences, Inc. (PLSE) Q3 2024 Earnings Call TranscriptOctober 31 at 8:55 AM | seekingalpha.comPulse Biosciences Inc (PLSE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...October 31 at 8:55 AM | finance.yahoo.comSee More Headlines PLSE Stock Analysis - Frequently Asked Questions How have PLSE shares performed this year? Pulse Biosciences' stock was trading at $12.24 on January 1st, 2024. Since then, PLSE stock has increased by 19.0% and is now trading at $14.56. View the best growth stocks for 2024 here. How were Pulse Biosciences' earnings last quarter? Pulse Biosciences, Inc. (NASDAQ:PLSE) released its quarterly earnings results on Wednesday, October, 30th. The company reported ($0.21) earnings per share for the quarter. When did Pulse Biosciences IPO? Pulse Biosciences (PLSE) raised $20 million in an initial public offering (IPO) on Wednesday, May 18th 2016. The company issued 5,000,000 shares at $4.00 per share. MDB Capital Group and Feltl and Company acted as the underwriters for the IPO. Who are Pulse Biosciences' major shareholders? Top institutional investors of Pulse Biosciences include Inspire Investing LLC (0.04%) and Creative Planning (0.04%). Insiders that own company stock include Mitchell E Levinson, Kevin Patrick Danahy and Burke Thomas Barrett. View institutional ownership trends. How do I buy shares of Pulse Biosciences? Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Pulse Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pulse Biosciences investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), Novo Nordisk A/S (NVO) and Jabil (JBL). Company Calendar Last Earnings10/30/2024Today11/02/2024Fiscal Year End12/31/2024Next Earnings (Estimated)3/27/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:PLSE CUSIPN/A CIK1625101 Webwww.pulsebiosciences.com Phone(510) 906-4600FaxN/AEmployees140Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-42,210,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-126.10% Return on Assets-91.24% Debt Debt-to-Equity RatioN/A Current Ratio4.57 Quick Ratio4.57 Sales & Book Value Annual Sales$700,000.00 Price / Sales1,274.83 Cash FlowN/A Price / Cash FlowN/A Book Value$0.81 per share Price / Book17.98Miscellaneous Outstanding Shares61,290,000Free Float17,468,000Market Cap$892.38 million OptionableOptionable Beta1.74 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:PLSE) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.